Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: NewCardio, Inc.

Market Cap 9L 8L 7L 7L 12.22L 8.13Cr 12.29L 82.56L 32L 4Cr 32.35L 31.66L 14Cr P/E 2009
-1.65x
P/E 2010 -2.11x
Enterprise Value 32.77L 28.57L 26.46L 24.77L 46.46L 31Cr 46.74L 3.14Cr 1.22Cr 15Cr 1.23Cr 1.2Cr 53Cr EV / Sales 2009
-
EV / Sales 2010 10,81,28,357x
Free-Float
75.73%
Yield 2009 *
-
Yield 2010 -
Change 5-day change 1-year change 3-year change Capi.($)
-2.50%+62.50% - - 40
+0.63%-1.01%+18.35%-13.53% 17TCr
+1.14%-1.04%-20.16%+23.51% 14TCr
-0.33%-1.63%-8.88%-26.73% 13TCr
+0.76%-3.45%-55.32%-16.62% 6.73TCr
+0.78%+2.64%+18.09%-4.98% 5.03TCr
-0.58%-1.16%-25.42%-34.65% 4.38TCr
+2.20%-2.14%+9.99%+4.90% 3.59TCr
-0.44%-0.03%+4.74%+32.04% 3.49TCr
+0.72%-5.51%-14.33%-21.69% 2.8TCr
Average +0.24%-1.86%-8.11%-6.42% 7.8TCr
Weighted average by Cap. +0.54%-1.89%-6.63%-6.41%

Financials

2009 2010
Net sales - 0.26 0.22 0.21 0.19 0.36 24.29 0.37 2.47 0.96 11.95 0.97 0.95 41.51
Net income -95.91L -83.62L -77.45L -72.5L -1.36Cr -90Cr -1.37Cr -9.19Cr -3.56Cr -45Cr -3.6Cr -3.52Cr -154.66Cr -1.15Cr -1Cr -92.83L -86.9L -1.63Cr -108.48Cr -1.64Cr -11Cr -4.27Cr -53Cr -4.32Cr -4.22Cr -185.4Cr
Net Debt -14.11L -12.3L -11.39L -10.67L -20L -13Cr -20.13L -1.35Cr -52.39L -6.55Cr -52.97L -51.83L -23Cr 24.15L 21.06L 19.5L 18.26L 34.24L 23Cr 34.45L 2.31Cr 89.66L 11Cr 90.65L 88.71L 39Cr
Logo NewCardio, Inc.
NewCardio, Inc. (NewCardio), through its wholly owned subsidiary, NewCardio Technologies, Inc. (NewCardio Technologies), operates as a development-stage cardiac diagnostic technology provider focused on the research, development and commercialization of products and services for the non-invasive diagnosis and monitoring of cardiovascular disease (CVD), as well as the cardiac safety assessment of new drugs under development. The Company is focused on the development of a platform technology for its products, which will improve the diagnostic accuracy and value of the standard 12-lead electrocardiogram (ECG). The Company’s core technology platform provides real-time, three-dimensional (3D) analysis of the heart's electrical activity, as detected at the body surface by standard 12-lead ECG electrodes. ECG input signals are typically sampled at 500 hertz (500 times per second).
Employees
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!